Lexeo Therapeutics (LXEO) News Today $4.90 +0.12 (+2.51%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$4.90 +0.00 (+0.02%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LXEO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period What is Chardan Capital's Forecast for LXEO FY2025 Earnings?August 23 at 7:45 AM | marketbeat.comInsider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 2,735 Shares of StockAugust 21 at 8:55 AM | insidertrades.comLexeo Therapeutics’ Friedreich Ataxia Gene Therapy Receives FDA Breakthrough Therapy DesignationAugust 20 at 2:03 AM | msn.comHC Wainwright Issues Pessimistic Forecast for Lexeo Therapeutics (NASDAQ:LXEO) Stock PriceAugust 18, 2025 | americanbankingnews.comLexeo Therapeutics (NASDAQ:LXEO) Given New $15.00 Price Target at Chardan CapitalAugust 17, 2025 | marketbeat.comLexeo Therapeutics (NASDAQ:LXEO) Announces Earnings ResultsAugust 17, 2025 | marketbeat.comLexeo Therapeutics (NASDAQ:LXEO) Given New $9.00 Price Target at HC WainwrightAugust 17, 2025 | marketbeat.comLexeo Therapeutics price target lowered to $15 from $20 at ChardanAugust 16, 2025 | msn.comLexeo Therapeutics reports Q2 EPS (60c) vs (64c) last yearAugust 14, 2025 | msn.comLexeo Therapeutics Appoints New Chief Financial OfficerAugust 14, 2025 | tipranks.comLexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 14, 2025 | globenewswire.comLexeo Therapeutics (NASDAQ:LXEO) Shares Up 1.8% - What's Next?August 10, 2025 | marketbeat.comLexeo Therapeutics (LXEO) Projected to Post Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of "Buy" from BrokeragesAugust 1, 2025 | marketbeat.comLexeo Therapeutics (NASDAQ:LXEO) Coverage Initiated by Analysts at OppenheimerAugust 1, 2025 | marketbeat.comOppenheimer Initiates Coverage of Lexeo Therapeutics (LXEO) with Outperform RecommendationAugust 1, 2025 | msn.comStifel Maintains Buy Rating on Lexeo Therapeutics (LXEO)July 29, 2025 | msn.comLexeo Therapeutics Holds 2025 Annual Stockholders MeetingJuly 25, 2025 | theglobeandmail.comLexeo Therapeutics (NASDAQ:LXEO) Shares Up 3.6% - Still a Buy?July 10, 2025 | marketbeat.comLexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia - MorningstarJuly 8, 2025 | morningstar.comMLexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia Treatment - NasdaqJuly 8, 2025 | nasdaq.comWhy Lexeo Is Rising In Pre-market? - NasdaqJuly 8, 2025 | nasdaq.comLexeo Therapeutics stock rises after FDA breakthrough designationJuly 8, 2025 | au.investing.comLexeo Therapeutics Shares Climb Following FDA Breakthrough Therapy DesignationJuly 8, 2025 | msn.comLexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich AtaxiaJuly 7, 2025 | globenewswire.comLexeo Therapeutics stockholders elect directors and ratify auditor at annual meeting - Investing.comJuly 2, 2025 | investing.comLexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA TherapeuticsJune 24, 2025 | globenewswire.comLexeo Therapeutics files to sell 41.63M shares of common stock for holdersJune 13, 2025 | msn.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Acquired by Millennium Management LLCJune 6, 2025 | marketbeat.comLexeo Therapeutics (NASDAQ:LXEO) Price Target Lowered to $10.00 at JPMorgan Chase & Co.May 31, 2025 | marketbeat.comLeerink Partnrs Issues Positive Forecast for LXEO EarningsMay 31, 2025 | marketbeat.comLexeo Therapeutics Announces $80 Mln Private Placement Of SharesMay 29, 2025 | nasdaq.comLexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular DiseasesMay 27, 2025 | globenewswire.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Buy" by BrokeragesMay 24, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Trims Holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)May 23, 2025 | marketbeat.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Holdings Lifted by Point72 Asset Management L.P.May 22, 2025 | marketbeat.comVestal Point Capital LP Raises Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO)May 21, 2025 | marketbeat.comQ1 Earnings Forecast for LXEO Issued By HC WainwrightMay 21, 2025 | marketbeat.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Stock Holdings Lifted by Janus Henderson Group PLCMay 17, 2025 | marketbeat.comLexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Superior Safety Profile Drive Buy RatingMay 16, 2025 | tipranks.comChardan Capital Has Lowered Expectations for Lexeo Therapeutics (NASDAQ:LXEO) Stock PriceMay 15, 2025 | marketbeat.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Sold by Omega Fund Management LLCMay 15, 2025 | marketbeat.comLexeo Therapeutics (NASDAQ:LXEO) Announces Earnings Results, Misses Expectations By $0.19 EPSMay 14, 2025 | marketbeat.comLexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational HighlightsMay 12, 2025 | globenewswire.comDAFNA Capital Management LLC Purchases 142,500 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO)May 10, 2025 | marketbeat.comLexeo: Alignment Gained With FDA Brings Further LX2006 Program AdvancementMay 5, 2025 | seekingalpha.comLexeo Therapeutics (LXEO) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comLexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual MeetingMay 1, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Sells 388,121 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO)April 29, 2025 | marketbeat.comLexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of "Buy" from BrokeragesApril 28, 2025 | marketbeat.com Get Lexeo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter. Email Address LXEO Media Mentions By Week LXEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXEO News Sentiment▼-0.140.66▲Average Medical News Sentiment LXEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXEO Articles This Week▼123▲LXEO Articles Average Week Get Lexeo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vir Biotechnology News Today AnaptysBio News Today Taysha Gene Therapies News Today Organogenesis News Today Theravance Biopharma News Today Maze Therapeutics News Today Maravai LifeSciences News Today Keros Therapeutics News Today Bicara Therapeutics News Today Relay Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LXEO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access